For the treatment of diabetes mellitus type 1 and 2 in adults
Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin Aspart (Fiasp®) is recommended for the treatment of diabetes mellitus in adults who are suitable for NovoRapid® and their diabetes cannot be adequately managed with alternative formulary choices and at least one of the following applies:
where the prescriber believes a faster onset of action would be beneficial to the patient
where a patient requires ‘tight’ control of blood sugar levels
where a patient has rapid post meal increase in blood sugar levels
Reason for decision:
Suitable for initiation in primary care in line with restrictions